bpc-157 oral vs injection dosage Protocol: Guide bpc 157 tb 500 oral
Description
Jeffrey Galvin serving as Medical Director
It is not intended for human consumption or medical use
Lipid panel: AOD-9604 is hypothesized to alter fat metabolism
Most metabolic peptides require subcutaneous injection, creating compliance barriers for chronic conditions like obesity
Consequently, this peptide garners the designation N-(trans-3-hexenoyl)-[Tyr1]hGRF(144)NH2 acetate
Drop back to the previous dose and attempt escalation again after an additional 2-4 weeks
